INTERNATIONAL BUSINESS MACHINES CO (IBM)
Sector: Information Technology
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Information Technology
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for IBM
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| IBM | Former Chairman and Chief Executive Officer; Lead Director | 65 | ["Former Chairman and Chief Executive Officer, Johnson & Johnson","Extensive global business experience and knowledge of financial and strategic issues and risk management as former executive chairman and chief executive officer of Johnson & Johnson","Deep understanding of complex operational issues facing multinational companies, including technology evolution and research and development","Public policy expertise as former Chair of the Business Roundtable’s Corporate Governance Committee and former member of the Business Council Executive Committee","active participation in the strategic planning of the Board agendas and meetings","authority to call meetings of the independent directors","liaison between the Chairman and the independent directors","reviews and approves meeting schedules","ensures availability for consultation with major stockholders","presides at all meetings of the Board when the Chairman is not present","conducts one-on-one debriefs with the Chairman after meetings","spends time with senior management to understand business and strategy","analyzes CEO performance","maintains regular contact with Board members","leads the Board self-evaluation process","attends all Board committee meetings"] | ["Audit","Executive"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| JPM | Director; Retired Chairman and Chief Executive Officer of Johnson & Johnson | 65 | ["Retired Chairman and Chief Executive Officer of Johnson & Johnson","Deep understanding of financial reporting standards","Expertise in overseeing innovative technologies","Seasoned executive experience operating in diverse geographic, political and regulatory environments","Broad governance expertise through public company board service"] | ["Audit","Corporate Governance & Nominating","Audit Committee","Corporate Governance & Nominating Committee"] | 2026 |
| AAPL | Former Chair and CEO, Johnson & Johnson; Director | 65 | ["executive leadership experience", "brand marketing expertise", "experience in health and technology"] | ["Nominating Committee", "People and Compensation Committee"] | 2026 |
| JNJ | Executive Chairman, Board of Directors; Executive Chairman of the Board | 61 | ["Leadership of global business in healthcare industry","Expertise in strategy and operations of our Company as well as its risks and challenges","Deep commitment to ethical, Credo-based leadership"] | ["Finance"] | 2022 |
Biography sourced from the proxy statement filing.
Mr. Gorsky, 65, is the former chairman and chief executive officer of Johnson & Johnson, and one of just seven leaders to have served in the dual role of chairman and chief executive officer since the company was listed on the New York Stock Exchange in 1944. He joined Johnson & Johnson in 1988 as a sales representative with Janssen Pharmaceutica. In 2003, he was named company group chairman of the Johnson & Johnson pharmaceutical business in Europe, the Middle East and Africa. Mr. Gorsky left Johnson & Johnson in 2004 to join the Novartis Pharmaceuticals Corporation, where he served as head of the company s pharmaceutical business in North America. Mr. Gorsky returned to Johnson & Johnson in 2008 as company group chairman for Ethicon. In early 2009, he was appointed worldwide chairman of the Surgical Care Group and member of the executive committee. In September 2009, he was appointed worldwide chairman of the Medical Devices and Diagnostics Group and became vice chairman of the executive committee in January 2011. He was named chief executive officer and joined the board of directors in April 2012, and was named chairman of the board of directors in December 2012. Mr. Gorsky remained chief executive officer until he transitioned to executive chairman at the end of 2021. He currently sits on the boards of Apple, JPMorgan Chase and the Travis Manion Foundation, and serves on the Board of Advisors for the Wharton School of the University of Pennsylvania.